Brian Chinnock, MD

Clinical Professor of Emergency Medicine

Location: UCSF Fresno

Specialty: Emergency Medicine

Biography

Additional titles:

Research Director, Emergency Medicine, UCSF Fresno
Director, SJV PRIME Arch, UCSF Fresno

Brian Chinnock, MD, is board certified in Emergency Medicine.

He earned his medical degree at University of Arizona, Tucson. His residency in Emergency Medicine was completed at University of California, San Francisco, Fresno where he served as a chief resident.

Dr. Chinnock has won many teaching awards including Top Resident Teacher and Top Medical Student Teacher at UCSF Fresno Department of Emergency Medicine and Outstanding Faculty Award at Texas Tech Health Sciences Center. He has also won the Faculty Research Award and the Henry J. Kaiser for Excellence in Teaching Award.

Publications

Chylothorax: case report and review of the literature.

Chinnock BF

Evaluation of an Alternative Approach to Managing Diabetic Ketoacidosis: Combination Rapid-Acting and Basal Subcutaneous Insulin (CRABI-DKA).

Ibarra F, Cruz M, Chinnock B, Sunde C, Campagne D, Uller M

Emergency Department Surveillance of Self-Reported Covid-19.

Reyes K, Chinnock B, Eucker SA, Rising KL, O'Laughlin KN, Rafique Z, Gottlieb M, Kumar VA, Rodriguez RM

Long COVID Among Undocumented Latino Immigrant Populations in the Emergency Department.

Reyes KP, Rafique Z, Chinnock B, Kumar VA, Gottlieb M, Rising KL, Rodriguez RM

Long COVID Illness: Disparities in Understanding and Receipt of Care in Emergency Department Populations.

Rodriguez RM, Reyes K, Kumar VA, Chinnock B, Eucker SA, Rising KL, Rafique Z, Gottlieb M, Nichol G, Morse D, Molina M, Arreguin MI, Shughart L, Conn C, Eckstrand S, Mesbah H, Chakraborty L, Welch RD

Demystifying Hispanic Versus Latino/a Versus Latinx: Which Do Emergency Department Patients Prefer?

Molina MF, Chary AN, Reyes K, Ford JS, Chinnock B, Rodriguez RM

Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023.

Plumb ID, Briggs Hagen M, Wiegand R, Dumyati G, Myers C, Harland KK, Krishnadasan A, James Gist J, Abedi G, Fleming-Dutra KE, Chea N, Lee JE, Kellogg M, Edmundson A, Britton A, Wilson LE, Lovett SA, Ocampo V, Markus TM, Smithline HA, Hou PC, Lee LC, Mower W, Rwamwejo F, Steele MT, Lim SC, Schrading WA, Chinnock B, Beiser DG, Faine B, Haran JP, Nandi U, Chipman AK, LoVecchio F, Eucker S, Femling J, Fuller M, Rothman RE, Curlin ME, Talan DA, Mohr NM, Vaccine Effectiveness among Healthcare Personnel Study Team

Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021-July 2022.

Plumb ID, Mohr NM, Hagen M, Wiegand R, Dumyati G, Harland KK, Krishnadasan A, Gist JJ, Abedi G, Fleming-Dutra KE, Chea N, Lee J, Barter D, Brackney M, Fridkin SK, Wilson LE, Lovett SA, Ocampo V, Phipps EC, Marcus TM, Smithline HA, Hou PC, Lee LC, Moran GJ, Krebs E, Steele MT, Lim SC, Schrading WA, Chinnock B, Beiser DG, Faine B, Haran JP, Nandi U, Chipman AK, LoVecchio F, Talan DA, Pilishvili T

Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Huang DQ, Ajmera V, Tomaszewski C, LaFree A, Bettencourt R, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Insel PA, Leachman S, Jung J, Collier S, Richards L, Woods K, Amangurbanova M, Bhatt A, Zhang X, Penciu OM, Zarich S, Retta T, Harkins MS, Teixeira JP, Chinnock B, Utay NS, Lake JE, Loomba R

Facemasks: Perceptions and use in an ED population during COVID-19.

Eswaran V, Chang AM, Wilkerson RG, O'Laughlin KN, Chinnock B, Eucker SA, Baumann BM, Anaya N, Miller DG, Haggins AN, Torres JR, Anderson ES, Lim SC, Caldwell MT, Raja AS, Rodriguez RM, REVVED-UP Investigators